Brief: Guard Therapeutics Q4 Loss SEK 26 Mln
Feb 20 (Reuters) - Guard Therapeutics International AB
(publ) GUARD.ST :
* Q4 NET SALES: 0 KSEK
* Q4 LOSS BEFORE AND AFTER TAX: SEK 26 MILLION
Source text: ID:nMFN403b2X
Further company coverage: GUARD.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Disruptive Pharma AB (publ)
See all newsBrief: Disruptive Pharma To Sell GTX Platform To Aurelia Invest AB Unit
Brief: Guard Therapeutics International Q2 Loss Before Tax SEK 4.4 Mln
Brief: Guard Therapeutics Gets Conditional Approval For Continued Listing
Brief: Guard Therapeutics International Initiates Deal Process For Gtx Platform
Brief: Guard Therapeutics Enters Conditional Deal For Reverse Takeover